MedPath

Effects of atorvastatin in traumatic brain injury

Not Applicable
Conditions
traumatic brain injury.
intracranial injury
Registration Number
IRCT2013041910178N5
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

all patients with traumatic brain injury exclusion criteria: hemorrhagic stroke; sensitivity to memantine; acute or chronic renal failure; acute or chronic hepatic disease; acute MI (<48 hours); autoimmune diseases; administration of atorvastatin during 6 months before stroke

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
euron specific enolase. Timepoint: Day 1,3,5. Method of measurement: Elisa kits.
Secondary Outcome Measures
NameTimeMethod
Glasgow Coma scale. Timepoint: fraom day 1 for 7days. Method of measurement: GCS chart.;Mortality. Timepoint: 90 days after trauma. Method of measurement: Will be checked by phone.
© Copyright 2025. All Rights Reserved by MedPath